Vascular Endothelial Growth Factor Levels in Patients Undergoing Embryo Transfer

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04261660

Enrollment

Registered

2020-02-10

Start date

2020-03-01

Completion date

2021-04-01

Last updated

2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reproductive Techniques

Brief summary

Assessing the relationship between the VEGF levels in blood and the IVF protocol

Detailed description

The investigators are assessing the VEGF levels in the blood in IVF patients undergoing different protocols

Interventions

OTHERNO intervention

NO INTERVENTION

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Inclusion criteria

Patients undergoing IVF -

Exclusion criteria

* Women with any malignancy * Patients request to be withdrawn

Design outcomes

Primary

Measure	Time frame	Description
vascular endothelial growth factor LEVELS	5 days	levels of vascular endothelial growth factor in blood

Contacts

Primary Contactido Fefekorn, MD

idofe@clalit.org.il+972-54-3537401

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026